OLIGONUCLEOTIDE MICROARRAYS FOR GENE EXPRESSION

Information

  • Research Project
  • 6294235
  • ApplicationId
    6294235
  • Core Project Number
    R43CA089984
  • Full Project Number
    1R43CA089984-01
  • Serial Number
    89984
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/1/2001 - 23 years ago
  • Project End Date
    6/30/2003 - 21 years ago
  • Program Officer Name
    HEART, LUNG, AND BLOOD INST., NATIONAL
  • Budget Start Date
    7/1/2001 - 23 years ago
  • Budget End Date
    6/30/2003 - 21 years ago
  • Fiscal Year
    2001
  • Support Year
    1
  • Suffix
  • Award Notice Date
    6/13/2001 - 23 years ago

OLIGONUCLEOTIDE MICROARRAYS FOR GENE EXPRESSION

APPLICANT?S DESCRIPTION: We will develop an ink-jet based microdispensing system for in situ synthesis of oligonucleotides in a microarray format for gene expression studies (expression chip). Multi-channel ink-jet devices will be utilized to increase throughput by an order of magnitude over single dispenser per base methods. The ink-jet based approach will: 1) allow flexibility in oligonucleotide design, 2) ensure high-throughput manufacture capabilities 3) provide a low cost alternative to current commercially available oligonucleotide-based microarrays, and 4) generate microarrays in a format that can be used with commercially available fluorescence detection scanners/instruments. The microarrays will facilitate the discovery of drug targets, which may interact with the genes and/or gene products expressed during the disease state. The toxicological and pharmacological responses to these drug leads can also be monitored. The use of such microchips will allow medical professionals to prescribe the most effective drugs, having the least side effects, based on a gene expression profile of an individual. Low cost microarrays will help to place this enabling technology into the hands of all researchers, thereby promoting our understanding of the changes in gene expression during cellular responses to developmental cues, physiological or pathological conditions, or external stimuli. PROPOSED COMMERCIAL APPLICATION: The in situ oligonucleotide synthesizer will provide low cost custom and "off-the-shelf" microarrays for various research applications. Data from such arrays can be used to build a bioinformatics database of gene expression profiles of cells and tissues under various conditions to provide for objective measurements of normal and disease states and disease associated pathways. Gene expression microarrays will also provide essential information for the characterization of normal versus diseased states, leading to the development of new treatment.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    99800
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
    NCI:99800\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MICROFAB TECHNOLOGIES, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    PLANO
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    75074
  • Organization District
    UNITED STATES